Metronomic oral palliative chemotherapy with capecitabine and cyclophosphamide in patients with anthracycline-, taxane- and platinum pretreated metastatic triple negative breast cancer: A single centre experience from developing country
twice in a day and oral cyclophosphamide at 50 mg/day without interruption until re-evaluation or progressive disease. Results: Between January 2008 and December 2013, 60 patients were enrolled

